A detailed history of North Forty Two & Co. transactions in Amgen Inc stock. As of the latest transaction made, North Forty Two & Co. holds 2,420 shares of AMGN stock, worth $718,667. This represents 0.73% of its overall portfolio holdings.

Number of Shares
2,420
Holding current value
$718,667
% of portfolio
0.73%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$258.78 - $328.31 $626,247 - $794,510
2,420 New
2,420 $631 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $159B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track North Forty Two & Co. Portfolio

Follow North Forty Two & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Forty Two & Co., based on Form 13F filings with the SEC.

News

Stay updated on North Forty Two & Co. with notifications on news.